SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR+34.0%
5Y CAGR+34.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+34.0%/yr
vs -30.2%/yr prior
5Y CAGR
+34.4%/yr
Consistent
Acceleration
+64.2pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
4.4x
Strong expansion
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.90% |
| Q3 2025 | 17.93% |
| Q2 2025 | 27.74% |
| Q1 2025 | 0.55% |
| Q4 2024 | 3.01% |
| Q3 2024 | 0.94% |
| Q2 2024 | 3.45% |
| Q1 2024 | 0.40% |
| Q4 2023 | -0.04% |
| Q3 2023 | -1.57% |
| Q2 2023 | 7.31% |
| Q1 2023 | 9.88% |
| Q4 2022 | 1.62% |
| Q3 2022 | -3.39% |
| Q2 2022 | 7.04% |
| Q1 2022 | 4.73% |
| Q4 2021 | 2.47% |
| Q3 2021 | 2.70% |
| Q2 2021 | 2.29% |
| Q1 2021 | -0.06% |
| Q4 2020 | 0.89% |
| Q3 2020 | -3.06% |
| Q2 2020 | 4.20% |
| Q1 2020 | 8.97% |
| Q4 2019 | -4.43% |
| Q3 2019 | 5.23% |
| Q2 2019 | -9.62% |
| Q1 2019 | 14.01% |
| Q4 2018 | 1.68% |
| Q3 2018 | 2.60% |
| Q2 2018 | -1.55% |
| Q1 2018 | 6.05% |
| Q4 2017 | 3.73% |
| Q3 2017 | -0.49% |
| Q2 2017 | -3.28% |
| Q1 2017 | 13.15% |
| Q4 2016 | 1.33% |
| Q3 2016 | -3.24% |
| Q2 2016 | -4.05% |
| Q1 2016 | 12.49% |